| UniProt ID | ITA7_HUMAN | |
|---|---|---|
| UniProt AC | Q13683 | |
| Protein Name | Integrin alpha-7 | |
| Gene Name | ITGA7 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1181 | |
| Subcellular Localization |
Membrane Single-pass type I membrane protein. |
|
| Protein Description | Integrin alpha-7/beta-1 is the primary laminin receptor on skeletal myoblasts and adult myofibers. During myogenic differentiation, it may induce changes in the shape and mobility of myoblasts, and facilitate their localization at laminin-rich sites of secondary fiber formation. It is involved in the maintenance of the myofibers cytoarchitecture as well as for their anchorage, viability and functional integrity. Isoform Alpha-7X2B and isoform Alpha-7X1B promote myoblast migration on laminin 1 and laminin 2/4, but isoform Alpha-7X1B is less active on laminin 1 (In vitro). Acts as Schwann cell receptor for laminin-2. Acts as a receptor of COMP and mediates its effect on vascular smooth muscle cells (VSMCs) maturation (By similarity). Required to promote contractile phenotype acquisition in differentiated airway smooth muscle (ASM) cells.. | |
| Protein Sequence | MAGARSRDPWGASGICYLFGSLLVELLFSRAVAFNLDVMGALRKEGEPGSLFGFSVALHRQLQPRPQSWLLVGAPQALALPGQQANRTGGLFACPLSLEETDCYRVDIDQGADMQKESKENQWLGVSVRSQGPGGKIVTCAHRYEARQRVDQILETRDMIGRCFVLSQDLAIRDELDGGEWKFCEGRPQGHEQFGFCQQGTAAAFSPDSHYLLFGAPGTYNWKGTARVELCAQGSADLAHLDDGPYEAGGEKEQDPRLIPVPANSYFGLLFVTNIDSSDPDQLVYKTLDPADRLPGPAGDLALNSYLGFSIDSGKGLVRAEELSFVAGAPRANHKGAVVILRKDSASRLVPEVMLSGERLTSGFGYSLAVADLNSDGWPDLIVGAPYFFERQEELGGAVYVYLNQGGHWAGISPLRLCGSPDSMFGISLAVLGDLNQDGFPDIAVGAPFDGDGKVFIYHGSSLGVVAKPSQVLEGEAVGIKSFGYSLSGSLDMDGNQYPDLLVGSLADTAVLFRARPILHVSHEVSIAPRSIDLEQPNCAGGHSVCVDLRVCFSYIAVPSSYSPTVALDYVLDADTDRRLRGQVPRVTFLSRNLEEPKHQASGTVWLKHQHDRVCGDAMFQLQENVKDKLRAIVVTLSYSLQTPRLRRQAPGQGLPPVAPILNAHQPSTQRAEIHFLKQGCGEDKICQSNLQLVRARFCTRVSDTEFQPLPMDVDGTTALFALSGQPVIGLELMVTNLPSDPAQPQADGDDAHEAQLLVMLPDSLHYSGVRALDPAEKPLCLSNENASHVECELGNPMKRGAQVTFYLILSTSGISIETTELEVELLLATISEQELHPVSARARVFIELPLSIAGMAIPQQLFFSGVVRGERAMQSERDVGSKVKYEVTVSNQGQSLRTLGSAFLNIMWPHEIANGKWLLYPMQVELEGGQGPGQKGLCSPRPNILHLDVDSRDRRRRELEPPEQQEPGERQEPSMSWWPVSSAEKKKNITLDCARGTANCVVFSCPLYSFDRAAVLHVWGRLWNSTFLEEYSAVKSLEVIVRANITVKSSIKNLMLRDASTVIPVMVYLDPMAVVAEGVPWWVILLAVLAGLLVLALLVLLLWKMGFFKRAKHPEATVPQYHAVKIPREDRQQFKEEKTGTILRNNWGSPRREGPDAHPILAADGHPELGPDGHPGPGTA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 6 (in isoform 13) | Phosphorylation | - | 40.27 | 23663014 | |
| 13 (in isoform 13) | Phosphorylation | - | 25.42 | 23663014 | |
| 14 (in isoform 13) | Phosphorylation | - | 17.29 | 23663014 | |
| 15 (in isoform 13) | Phosphorylation | - | 0.98 | 23663014 | |
| 50 | Phosphorylation | RKEGEPGSLFGFSVA HCCCCCCCHHEEEEE | 31.10 | - | |
| 86 | N-linked_Glycosylation | ALPGQQANRTGGLFA CCCCCCCCCCCCCCC | 37.40 | UniProtKB CARBOHYD | |
| 127 | Phosphorylation | ENQWLGVSVRSQGPG CCCEEEEEEEECCCC | 15.26 | 23403867 | |
| 130 | Phosphorylation | WLGVSVRSQGPGGKI EEEEEEEECCCCCEE | 37.02 | 23403867 | |
| 156 | Phosphorylation | RVDQILETRDMIGRC HHHHHHHHHHHHHHH | 28.64 | 24505115 | |
| 306 | Phosphorylation | GDLALNSYLGFSIDS HCHHHHHHCCEEECC | 15.12 | 22461510 | |
| 313 | Phosphorylation | YLGFSIDSGKGLVRA HCCEEECCCCCEEEH | 40.51 | 22461510 | |
| 345 | Phosphorylation | VVILRKDSASRLVPE EEEEECCCHHHHCCE | 31.04 | 27282143 | |
| 347 | Phosphorylation | ILRKDSASRLVPEVM EEECCCHHHHCCEEE | 30.05 | 24505115 | |
| 413 | Phosphorylation | GGHWAGISPLRLCGS CCCCCCCCCHHCCCC | 19.57 | 24719451 | |
| 526 | Phosphorylation | LHVSHEVSIAPRSID EEEECEEEECCCCCC | 15.28 | 24719451 | |
| 638 | Phosphorylation | RAIVVTLSYSLQTPR HHHHHEEEHHCCCHH | 11.87 | - | |
| 689 | Phosphorylation | GEDKICQSNLQLVRA CCCCHHHHHHHHHHH | 34.79 | 28102081 | |
| 786 | N-linked_Glycosylation | PLCLSNENASHVECE CEECCCCCCCCEEEE | 51.50 | UniProtKB CARBOHYD | |
| 876 | Phosphorylation | RGERAMQSERDVGSK CCCHHCCCCCCCCCE | 22.86 | 30631047 | |
| 886 | Phosphorylation | DVGSKVKYEVTVSNQ CCCCEEEEEEEECCC | 20.72 | 24043423 | |
| 889 | Phosphorylation | SKVKYEVTVSNQGQS CEEEEEEEECCCCCE | 13.28 | 24043423 | |
| 891 | Phosphorylation | VKYEVTVSNQGQSLR EEEEEEECCCCCEEE | 17.67 | 24043423 | |
| 896 | Phosphorylation | TVSNQGQSLRTLGSA EECCCCCEEEEEHHH | 27.00 | 24043423 | |
| 911 | Ubiquitination | FLNIMWPHEIANGKW HHHHHCCHHHHCCCE | 24.47 | 21890473 | |
| 911 (in isoform 9) | Ubiquitination | - | 24.47 | 21890473 | |
| 937 (in isoform 3) | Phosphorylation | - | 24.83 | 24719451 | |
| 977 | Phosphorylation | ERQEPSMSWWPVSSA CCCCCCCCCCCCCCH | 30.26 | 24719451 | |
| 987 | Ubiquitination | PVSSAEKKKNITLDC CCCCHHHCCCEEEEE | 42.42 | - | |
| 988 | Ubiquitination | VSSAEKKKNITLDCA CCCHHHCCCEEEEEC | 65.73 | - | |
| 989 | N-linked_Glycosylation | SSAEKKKNITLDCAR CCHHHCCCEEEEECC | 41.16 | UniProtKB CARBOHYD | |
| 1025 | N-linked_Glycosylation | HVWGRLWNSTFLEEY HHHHHHHCCHHHHHH | 35.45 | 19159218 | |
| 1045 | N-linked_Glycosylation | LEVIVRANITVKSSI EEEEHHCCEEECHHH | 21.65 | UniProtKB CARBOHYD | |
| 1047 | Phosphorylation | VIVRANITVKSSIKN EEHHCCEEECHHHHH | 22.99 | 29449344 | |
| 1050 | Phosphorylation | RANITVKSSIKNLML HCCEEECHHHHHHCC | 32.72 | 29449344 | |
| 1051 | Phosphorylation | ANITVKSSIKNLMLR CCEEECHHHHHHCCC | 31.68 | 29449344 | |
| 1051 (in isoform 9) | Ubiquitination | - | 31.68 | - | |
| 1082 (in isoform 7) | Ubiquitination | - | 10.28 | 21890473 | |
| 1086 (in isoform 3) | Ubiquitination | - | 1.49 | 21890473 | |
| 1086 | Ubiquitination | GVPWWVILLAVLAGL CCCHHHHHHHHHHHH | 1.49 | 21890473 | |
| 1110 (in isoform 3) | Phosphorylation | - | 49.54 | 24719451 | |
| 1122 | Phosphorylation | PEATVPQYHAVKIPR CCCCCCCCEEEECCH | 5.91 | 27642862 | |
| 1126 (in isoform 1) | Ubiquitination | - | 48.02 | 21890473 | |
| 1126 | Ubiquitination | VPQYHAVKIPREDRQ CCCCEEEECCHHHHH | 48.02 | 2189047 | |
| 1150 | Phosphorylation | ILRNNWGSPRREGPD CCCCCCCCCCCCCCC | 13.57 | 26029660 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ITA7_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ITA7_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ITA7_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| FHL2_HUMAN | FHL2 | physical | 15117962 | |
| FHL3_HUMAN | FHL3 | physical | 15117962 | |
| ACHA_HUMAN | CHRNA1 | physical | 10910772 | |
| ITB1_HUMAN | ITGB1 | physical | 11278916 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| H00590 | Congenital muscular dystrophies (CMD/MDC), including: Merosin-deficient CMD (MDC1A); Ullrich CMD (UC | |||||
| OMIM Disease | ||||||
| 613204 | Muscular dystrophy congenital due to integrin alpha-7 deficiency (MDCI) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1025, AND MASSSPECTROMETRY. | |